Petvivo Holdings, Inc. Appoints Dr. David B. Masters as Director of Science and Technology
September 18, 2020 at 02:47 am IST
Share
PetVivo Holdings, Inc. Board of Directors announced that Dr. David B. Masters has been appointed as Director of Science and Technology of the Company, effective September 1, 2020. Dr. Masters will act as the Company's primary representative involving the Company's science and technology. The Company and Dr. Masters entered into a consulting agreement (the "Consulting Agreement") having an Effective Date of September 1, 2020, pursuant to which Dr. Masters will serve as the Director of Science and Technology of the Company.
PetVivo Holdings, Inc. is a biomedical device company. The Company is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Companyâs lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The Company is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a bodyâs cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The Company has a pipeline of therapeutic devices for both veterinary and human clinical applications.
PETVIVO HOLDINGS, INC. 
